Large-scale testing (Phase 3)Ended earlyNCT01770379
What this trial is testing
Secukinumab Efficacy and Safety Study in Patients With Rheumatoid Arthritis and Inadequate Response to Anti-TNFα Agents.
Who this might be right for
Rheumatoid Arthritis
Novartis Pharmaceuticals 242